October 13, 2026 by Mohr Marketing
More birth injury inquiries do not automatically mean more viable cases. If inquiry volume rises without matching your firmβs criteria, it can strain...
October 8, 2026 by Mohr Marketing
A high volume of inquiries does not guarantee a strong malpractice caseload. Medical malpractice leads are useful when they align with your firmβs...
October 7, 2026 by Mohr Marketing
What if a lead you pay for does not meet your firmβs case criteria? Pay per lead legal marketing can make acquisition spending easier to track, but a...
October 6, 2026 by Mohr Marketing
An βexclusiveβ label does not prove that an inquiry is being sent to only your firm, that it meets your criteria, or that the person is ready to...
October 4, 2026 by Mohr Marketing
What if more auto accident inquiries are making your case pipeline less reliable, not more? Lead volume can look strong while masking incomplete...
September 30, 2026 by Mohr Marketing
A high count of ozempic lawsuit leads can look like momentum, but volume alone doesnβt show whether inquiries match a firmβs current criteria,...
September 28, 2026 by Mohr Marketing
More claimant inquiries do not automatically create a stronger NEC campaign. Effective NEC baby formula case acquisition depends on written screening...
September 25, 2026 by Mohr Marketing
What if your highest-volume marketing channel is also your least valuable one? Tracking marketing effectiveness for law firms means looking beyond...
September 25, 2026 by Mohr Marketing
What if the biggest threat to high-value mold case acquisition isnβt a lack of leads, but a process that fails to separate credible claims from...
September 17, 2026 by Mohr Marketing
Volume is no longer a competitive advantage in personal injury marketing. If your firm is still competing for raw motor vehicle accident leads...